DARE
#4544
Dare Bioscience, Inc. - Common Stock
1.4 4 USD
+0.06%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+5.88%
Monthly Change
-28.00%
6 month change
-12.73%
Year Change
-12.73%
Previous Close
1.3 6
Open
1.4 4
Low
1.4 4
High
1.4 4
Volume
4
Financials
- Market Capitalization 21.57 M
- Employee 24
- Founded 2005
- CEO Sabrina Martucci Johnson
- Website www.darebioscience.com
- Headquarter Delaware, United States
- FIGI BBG001J2P362
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.61
Price to sales ratio
20.94
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4531 |  RADX Radiopharm Theranostics Limited American Depositary Shares | 2.84 USD | +1.43% | -2.74% | -33.18% | -46.72% | 22.39 M USD | ||
| 4533 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.86 USD | -0.65% | +12.59% | +1.61% | +136.92% | 22.44 M USD | ||
| 4550 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 2.65 USD | +1.92% | +3.52% | -5.69% | -15.61% | 21.18 M USD | ||
| 4552 |  NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.81 USD | -0.78% | -2.06% | +7.63% | -47.74% | 20.59 M USD |
Frequently asked questions about Dare Bioscience, Inc. - Common Stock
What is the Dare Bioscience, Inc. - Common Stock stock price today?
The current price of Dare Bioscience, Inc. - Common Stock (DARE) is 1.44. Over the past 24 hours, the stock has changed by +5.88%. Follow the DARE chart for real-time price dynamics.
What is the stock ticker of Dare Bioscience, Inc. - Common Stock?
Dare Bioscience, Inc. - Common Stock trades under the ticker DARE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Dare Bioscience, Inc. - Common Stock stock going up?
DARE has changed by +9.09% over the last week, -28.00% over the last month, and -12.73% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Dare Bioscience, Inc. - Common Stock?
Dare Bioscience, Inc. - Common Stock currently has a market capitalization of 21.57 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Dare Bioscience, Inc. - Common Stock earnings last quarter?
Last quarter, Dare Bioscience, Inc. - Common Stock reported earnings of -0.21 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Dare Bioscience, Inc. - Common Stock revenue for the last quarter?
Dare Bioscience, Inc. - Common Stock reported quarterly revenue of 152.45 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Dare Bioscience, Inc. - Common Stock net income for the last quarter?
Dare Bioscience, Inc. - Common Stock reported net income of -3 M for the last quarter. The previous quarter showed -1.44 M, which means net income changed by -108.08%.
How many employees does Dare Bioscience, Inc. - Common Stock have?
As of the latest available data, Dare Bioscience, Inc. - Common Stock has 24 employees. Workforce size can provide additional context about the company's scale and operations.
What is Dare Bioscience, Inc. - Common Stock EBITDA?
Dare Bioscience, Inc. - Common Stock EBITDA is -2.44 M, and its EBITDA margin is -1 603.26%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Dare Bioscience, Inc. - Common Stock stock?
You can buy Dare Bioscience, Inc. - Common Stock (DARE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Dare Bioscience, Inc. - Common Stock stock?
Investing in Dare Bioscience, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DARE chart and related analysis on metatrader.com as part of your research.